| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000028987 |
| Receipt No. | R000033166 |
| Official scientific title of the study | Safety evaluation studies of high dose intake of capsules including herb extract |
| Date of disclosure of the study information | 2017/09/07 |
| Last modified on | 2018/02/28 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | Safety evaluation studies of high dose intake of capsules including herb extract | |
| Title of the study (Brief title) | Safety evaluation studies of high dose intake of capsules including herb extract | |
| Region |
|
|
| Condition | ||
| Condition | Healthy adult | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To evaluate the safety of excessive ingestion of foods containing herb extract,
5-fold quantity of recommended daily intake. |
| Basic objectives2 | Safety |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Hematologic test
Blood biochemistry test Urine analysis Blood pressure/pulsation Weight/ body mass index Doctor's questions Adverse event Evaluate at points of 2 week and 4 week of ingestion and 2 weeks after the end of ingestion period |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | Oral ingestion of the test product 10 grains per day, 4 weeks. | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Adult males and females from 20 to 64 years of age | |||
| Key exclusion criteria | (1) Subjects who routinely use health food richly containing herb extract
(2) Subjects judged as unsuitable for this study based on the results of clinical examination or cardiopulmonary abnormality (3) Subjects having possibilities for emerging allergy related to the study (4) Subjects having a disease requiring regular medication or a history of serious diseases for which medication was required (5) Subjects who are judged as unsuitable for the study based on the results of clinical and physical examination on preliminary examination (6) Subjects who have participated in other clinical studies (7) Subjects who intend to become pregnant or lactating (8) Subjects who are judged as unsuitable for the study based on the results of lifestyle questionnaire (9) Subjects judged as unsuitable for the study by the investigator for other reasons |
|||
| Target sample size | 10 | |||
| Research contact person | |
| Name of lead principal investigator | Hirohide Sakaguchi |
| Organization | Nippon Shinyaku Co.,Ltd. |
| Division name | Food Development Labs. |
| Address | 14,Nishinosho-monguchi-cho,Kisshoin, Minami-ku,Kyoto |
| TEL | 075-321-9027 |
| h.sakaguchi@po.nippon-shinyaku.co.jp | |
| Public contact | |
| Name of contact person | Kunihiko Wasaki |
| Organization | TTC Co., Ltd. |
| Division name | Clinical Research Planning Department |
| Address | 1-20-2, Ebisunishi, shibuya-ku, Tokyo |
| TEL | 03-5459-5329 |
| Homepage URL | |
| k.wasaki@ttc-tokyo.co.jp | |
| Sponsor | |
| Institute | TTC Co., Ltd. |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Nippon Shinyaku Co.,Ltd. |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000033166 |